RenovoRx
RNXT
11 hedge funds and large institutions have $2.75M invested in RenovoRx in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
11% more capital invested
Capital invested by funds: $2.49M → $2.75M (+$261K)
0.72% less ownership
Funds ownership: 13.56% → 12.85% (-0.72%)
15% less funds holding
Funds holding: 13 → 11 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Affinity Capital Advisors
Berkeley,
California
|
+$7.66K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.45K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$241 |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$64.2K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
-$64K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$722 |
| 5 |
Morgan Stanley
New York
|
-$191 |
RNXT Hedge Fund Activity: Q4 2022 in Review
11 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q4 2022, worth a combined $2.75M — up 11% from $2.49M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RNXT and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Affinity Capital Advisors, adding an estimated $7.66K. The largest seller was Bank of America, cutting an estimated $64.2K.
- 11 institutional investors held RenovoRx (RNXT) as of Q4 2022, down from 13 in Q3 2022.
- Funds reported $2.75M of RenovoRx stock for Q4 2022, up 11% quarter-over-quarter.
- 0 funds opened new RenovoRx positions in Q4 2022 and 2 closed out, a net change of -2 holders.
- The largest RenovoRx buyer in Q4 2022 was Affinity Capital Advisors, an estimated $7.66K added.
- The largest RenovoRx seller in Q4 2022 was Bank of America, an estimated $64.2K sold.
Based on aggregated 13F filings for Q4 2022.